ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of
wafer processing solutions for semiconductor and advanced packaging
applications, today reported financial results for its fourth
quarter and fiscal year ended December 31, 2024.
“2024 was a year of strong execution for ACM. We
expanded our product portfolio and broadened the addressable
markets we serve,” said ACM’s President and Chief Executive
Officer, Dr. David Wang. “We grew revenue by 40% and total
shipments by 63%. We gained additional market share by capitalizing
on product cycles and deepening engagements with key customers,
demonstrating the strength of our multi-product portfolio. Our
operating profit increased by 57.6%, and we generated $152 million
in cash flow from operations.”
Dr. Wang continued, “In the fourth quarter, we
achieved two major operational milestones. First, we achieved
process qualification of our Thermal and Plasma-Enhanced ALD
furnace tools at two semiconductor customers in mainland China.
Second, we commenced initial operations at our Lingang production
facility, and we are on track to transition additional capacity to
Lingang as we progress through the year.”
Dr. Wang concluded, “Looking ahead to 2025, we
remain focused on expanding our business with incremental revenue
contribution from Tahoe, SPM, and Furnace, additional customer
evaluations for both Track and PECVD, increasing localization in
China, and contributions from our expanding global footprint.
Regarding the addition of our subsidiaries to the U.S. Entity List,
we believe the impact on the ability of ACM Research (Shanghai) to
produce tools will be manageable, and that we can continue to
support our global customer base.”
|
Three Months Ended December 31, |
|
GAAP |
|
Non-GAAP(1) |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(dollars in thousands, except EPS) |
Revenue |
$ |
223,471 |
|
|
$ |
170,321 |
|
|
$ |
223,471 |
|
|
$ |
170,321 |
|
Gross margin |
|
49.6 |
% |
|
|
46.4 |
% |
|
|
49.8 |
% |
|
|
46.8 |
% |
Income from operations |
$ |
43,989 |
|
|
$ |
23,374 |
|
|
$ |
52,773 |
|
|
$ |
36,046 |
|
Net income attributable to ACM
Research, Inc. |
$ |
31,080 |
|
|
$ |
17,700 |
|
|
$ |
37,740 |
|
|
$ |
28,681 |
|
Basic EPS |
$ |
0.49 |
|
|
$ |
0.29 |
|
|
$ |
0.60 |
|
|
$ |
0.47 |
|
Diluted EPS |
$ |
0.46 |
|
|
$ |
0.26 |
|
|
$ |
0.56 |
|
|
$ |
0.43 |
|
|
Twelve Months Ended December 31, |
|
GAAP |
|
Non-GAAP(1) |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(dollars in thousands, except EPS) |
Revenue |
$ |
782,118 |
|
|
$ |
557,723 |
|
|
$ |
782,118 |
|
|
$ |
557,723 |
|
Gross margin |
|
50.1 |
% |
|
|
49.5 |
% |
|
|
50.4 |
% |
|
|
49.8 |
% |
Income from
operations |
$ |
150,998 |
|
|
$ |
95,839 |
|
|
$ |
200,574 |
|
|
$ |
123,177 |
|
Net income
attributable to ACM Research, Inc. |
$ |
103,627 |
|
|
$ |
77,349 |
|
|
$ |
152,230 |
|
|
$ |
107,424 |
|
Basic EPS |
$ |
1.67 |
|
|
$ |
1.29 |
|
|
$ |
2.45 |
|
|
$ |
1.79 |
|
Diluted EPS |
$ |
1.53 |
|
|
$ |
1.16 |
|
|
$ |
2.26 |
|
|
$ |
1.63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Reconciliations to U.S. generally accepted accounting principles
(“GAAP”) financial measures from non-GAAP financial measures are
presented below under “Reconciliation of GAAP to Non-GAAP Financial
Measures.” Non-GAAP financial measures exclude stock-based
compensation and, with respect to net income (loss) attributable to
ACM Research, Inc. and basic and diluted earnings per share, also
exclude unrealized gain (loss) on short-term investments. |
Outlook
ACM is maintaining its revenue guidance range of
$850 million to $950 million for fiscal year 2025. This expectation
is based on ACM management’s current assessment of the continuing
impact from international trade policy, together with various
expected spending scenarios of key customers, supply chain
constraints, and the timing of acceptances for first tools under
evaluation in the field, among other factors. We have updated our
long-term business model to a gross margin target range of 42% to
48%, versus the prior range of 40% to 45%.
Operating Highlights and Recent
Announcements
-
Shipments. Total shipments in 2024 were $973
million, up 63.1%. Total shipments in the fourth quarter of 2024
were $264 million, versus $140 million in the fourth quarter of
2023. Total shipments include deliveries for revenue in the quarter
and deliveries of first tool systems awaiting customer acceptance
for potential revenue in future quarters.
- Thermal and Plasma-Enhanced
ALD furnace tools achieved process qualification. ACM
announced the achievement of process qualification of its Ultra Fn
A Plasma-Enhanced Atomic Layer Deposition (PEALD) and Thermal
Atomic Layer Deposition (Thermal ALD) Furnace tools at two mainland
China semiconductor customers.
Full Year 2024 Financial Summary
Unless otherwise noted, the following
figures refer to the full year of 2024 and comparisons are with the
full year of 2023.
-
Revenue was $782.1 million, up 40.2%, reflecting
higher sales of single wafer cleaning, Tahoe and semi-critical
cleaning equipment and ECP (front-end and packaging), furnace and
other technologies, along with steady growth of advanced packaging
(excluding ECP), services & spares.
- Gross
margin was 50.1% versus 49.5%. Non-GAAP gross margin,
which excludes stock-based compensation, was 50.4% versus 49.8%.
Gross margin exceeded ACM’s updated long-term business model target
range of 42% to 48%. ACM expects gross margin to vary from period
to period due to a variety of factors, such as product mix,
currency impacts and sales volume.
- Operating
expenses were $240.6 million, an increase of 33.4%.
Operating expenses as a percentage of revenue decreased to 30.8%
from 32.3%. Non-GAAP operating expenses, which exclude the effect
of stock-based compensation, were $193.4 million, up 25.2%.
Non-GAAP operating expenses as a percentage of revenue were 24.7%
compared to 27.7%.
- Operating
income was $151.0 million, up 57.6% compared to $95.8
million. Operating margin increased from 17.2% to 19.3%. Non-GAAP
operating income, which excludes the effect of stock-based
compensation, was $200.6 million, up 62.8% compared to 123.2
million. Non-GAAP operating margin, which excludes stock-based
compensation, was 25.6% compared to 22.1%.
- Unrealized
gain (loss) on short-term investments was $1.0 million,
compared to an unrealized gain (loss) of $(2.7) million. Unrealized
gain (loss) reflects the change in market value of the investments
by ACM’s principal operating subsidiary, ACM Research (Shanghai),
Inc. The value is marked-to-market quarterly and is excluded in the
non-GAAP financial metrics.
- Income tax
expense was $35.0 million, compared to $19.4 million.
- Net income
attributable to ACM Research, Inc. was $103.6 million,
compared to $77.3 million. Non-GAAP net income attributable to ACM
Research, Inc., which excludes the effect of stock-based
compensation and unrealized gain (loss) on short-term investments,
was $152.2 million, compared to $107.4 million.
- Net income
per diluted share attributable to ACM Research, Inc. was
$1.53, compared to $1.16. Non-GAAP net income per diluted share,
which excludes the effect of stock-based compensation and
unrealized gain (loss) on short-term investments, was $2.26,
compared to $1.63.
- Cash and
cash equivalents, plus restricted cash and short-term and
long-term time deposits were $441.9 million at December 31, 2024,
compared to $369.1 million at September 30, 2024.
Fourth Quarter 2024 Financial Summary
Unless otherwise noted, the following
figures refer to the fourth quarter of 2024 and comparisons are
with the fourth quarter of 2023.
-
Revenue was $223.5 million, up 31.2%, reflecting
higher sales of single wafer cleaning, Tahoe and semi-critical
cleaning equipment and ECP (front-end and packaging), furnace and
other technologies, along with steady sales growth of advanced
packaging (excluding ECP), services & spares.
- Gross
margin was 49.6% versus 46.4%. Non-GAAP gross margin,
which excludes stock-based compensation, was 49.8% versus 46.8%.
Gross margin was at the upper end of ACM’s updated long-term
business model target range of 42% to 48%. ACM expects gross margin
to vary from period to period due to a variety of factors, such as
product mix, currency impacts and sales volume.
- Operating
expenses were $66.8 million, an increase of 20.0%.
Operating expenses as a percentage of revenue decreased to 29.9%
from 32.7%. Non-GAAP operating expenses, which exclude the effect
of stock-based compensation, were $58.4 million, up 34.0%. Non-GAAP
operating expenses as a percentage of revenue increased to 26.1%
from 25.6%.
- Operating
income was $44.0 million, up 88.2% compared to $23.4
million. Operating margin was 19.7% compared to 13.7%. Non-GAAP
operating income, which excludes the effect of stock-based
compensation, was $52.8 million, up 46.4% compared to $36.0
million. Non-GAAP operating margin, which excludes stock-based
compensation, was 23.6% compared to 21.2%.
- Unrealized
gain on short-term investments was $2.1 million, compared
to an unrealized gain of $1.7 million. Unrealized gain reflects the
change in market value of the investments by ACM’s principal
operating subsidiary, ACM Research (Shanghai), Inc. The value is
marked-to-market quarterly and is excluded in the non-GAAP
financial metrics.
- Income tax
expense was $17.3 million, compared to $8.1 million.
- Net income
attributable to ACM Research, Inc. was $31.1 million,
compared to $17.7 million. Non-GAAP net income attributable to ACM
Research, Inc., which excludes the effect of stock-based
compensation and unrealized gain on short-term investments, was
$37.7 million, compared to $28.7 million.
- Net income
per diluted share attributable to ACM Research, Inc. was
$0.46, compared to $0.26. Non-GAAP net income per diluted share,
which excludes the effect of stock-based compensation and
unrealized gain on short-term investments, was $0.56, compared to
$0.43.
Conference Call Details
A conference call to discuss results will be
held on Wednesday, February 26, 2025, at 8:00 a.m. Eastern Time
(9:00 p.m. China Time). To join the conference call via telephone,
participants must use the following link to complete an online
registration process. Upon registering, each participant will
receive email instructions to access the conference call, including
dial-in information and a PIN number allowing access to the
conference call. This pre-registration process is designed by the
operator to reduce delays due to operator congestion when accessing
the live call.
Online Registration:
https://register.vevent.com/register/BI70ae79d80e0348a880269ad7a9dec2f9
Participants who have not pre-registered may
join the webcast by accessing the link at
ir.acmrcsh.com/events.
A live and archived webcast will be available on
the Investors section of the ACM website at www.acmrcsh.com.
Use of Non-GAAP Financial
Measures
ACM presents non-GAAP gross margin, operating
expenses, operating income, net income attributable to ACM
Research, Inc. and basic and diluted earnings per share as
supplemental measures to GAAP financial measures regarding ACM’s
operational performance. These supplemental measures exclude the
impact of stock-based compensation, which ACM does not believe is
indicative of its core operating results. In addition, non-GAAP net
income attributable to ACM Research, Inc. and basic and diluted
earnings per share exclude the effect of stock-based compensation
and unrealized gain (loss) on short-term investments, which ACM
also believes are not indicative of its core operating results. A
reconciliation of each non-GAAP financial measure to the most
directly comparable GAAP financial measure is provided below under
“Reconciliation of GAAP to non-GAAP Financial Measures.”
ACM believes these non-GAAP financial measures
are useful to investors in assessing its operating performance. ACM
uses these financial measures internally to evaluate its operating
performance and for planning and forecasting of future periods.
Financial analysts may focus on and publish both historical results
and future projections based on the non-GAAP financial measures.
ACM also believes it is in the best interests of investors for ACM
to provide this non-GAAP information.
While ACM believes these non-GAAP financial
measures provide useful supplemental information to investors,
there are limitations associated with the use of these non-GAAP
financial measures. These non-GAAP financial measures may not be
reported by competitors, and they may not be directly comparable to
similarly titled measures of other companies due to differences in
calculation methodologies. The non-GAAP financial measures are not
an alternative to GAAP information and are not meant to be
considered in isolation or as a substitute for comparable GAAP
financial measures. They should be used only as a supplement to
GAAP information and should be considered only in conjunction with
ACM’s consolidated financial statements prepared in accordance with
GAAP.
Forward-Looking Statements
Certain statements contained in this press
release are not historical facts and may be forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Words such as “plans,” “expects,” “believes,”
“anticipates,” “designed,” and similar words are intended to
identify forward-looking statements. Forward-looking statements are
based on ACM management’s current expectations and beliefs, and
involve a number of risks and uncertainties that are difficult to
predict and that could cause actual results to differ materially
from those stated or implied by the forward-looking statements. A
description of certain of these risks, uncertainties and other
matters can be found in filings ACM makes with the U.S. Securities
and Exchange Commission, all of which are available at www.sec.gov.
Because forward-looking statements involve risks and uncertainties,
actual results and events may differ materially from results and
events currently expected by ACM. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. ACM undertakes no obligation to
publicly update these forward-looking statements to reflect events
or circumstances that occur after the date hereof or to reflect any
change in its expectations with regard to these forward-looking
statements or the occurrence of unanticipated events.
About ACM Research, Inc.
ACM develops, manufactures and sells
semiconductor process equipment spanning cleaning, electroplating,
stress-free polishing, vertical furnace processes, track, PECVD,
and wafer- and panel-level packaging tools, enabling advanced and
semi-critical semiconductor device manufacturing. ACM is committed
to delivering customized, high-performance, cost-effective process
solutions that semiconductor manufacturers can use in numerous
manufacturing steps to improve productivity and product yield. For
more information, visit www.acmrcsh.com.
© ACM Research, Inc. ULTRA Fn and the ACM Research logo are
trademarks of ACM Research, Inc. For convenience, these trademarks
appear in this press release without ™ symbols, but that practice
does not mean that ACM will not assert, to the fullest extent under
applicable law, its rights to the trademarks.
For investor and media inquiries, please
contact:
In the United States: |
The Blueshirt Group |
|
Steven
C. Pelayo, CFA |
|
(360)808-5154 |
|
steven@blueshirtgroup.co |
|
|
In China: |
The
Blueshirt Group Asia |
|
Gary
Dvorchak, CFA |
|
+86
(138) 1079-1480 |
|
gary@blueshirtgroup.co |
ACM RESEARCH, INC. |
Condensed Consolidated Balance Sheets |
|
|
December 31, 2024 |
|
December 31, 2023 |
|
(Unaudited) |
|
|
|
(In thousands) |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
407,445 |
|
|
$ |
182,090 |
|
Restricted cash |
|
3,865 |
|
|
|
1,083 |
|
Short-term time deposits |
|
17,277 |
|
|
|
80,524 |
|
Short-term investment |
|
19,373 |
|
|
|
21,312 |
|
Accounts receivable, net |
|
387,045 |
|
|
|
283,186 |
|
Other receivables |
|
41,859 |
|
|
|
40,065 |
|
Inventories, net |
|
597,984 |
|
|
|
545,395 |
|
Advances to related party |
|
1,024 |
|
|
|
2,432 |
|
Prepaid expenses |
|
7,507 |
|
|
|
20,023 |
|
Total current assets |
|
1,483,379 |
|
|
|
1,176,110 |
|
Property, plant and equipment,
net |
|
269,272 |
|
|
|
201,848 |
|
Operating lease right-of-use
assets, net |
|
14,038 |
|
|
|
15,393 |
|
Intangible assets, net |
|
3,461 |
|
|
|
2,538 |
|
Long-term time deposits |
|
13,275 |
|
|
|
40,818 |
|
Deferred tax assets |
|
14,781 |
|
|
|
20,271 |
|
Long-term investments |
|
37,063 |
|
|
|
27,880 |
|
Other long-term assets |
|
20,452 |
|
|
|
6,050 |
|
Total assets |
$ |
1,855,721 |
|
|
$ |
1,490,908 |
|
Liabilities and Equity |
|
|
|
Current liabilities: |
|
|
|
Short-term borrowings |
$ |
32,814 |
|
|
$ |
31,335 |
|
Current portion of long-term
borrowings |
|
44,472 |
|
|
|
6,783 |
|
Related party accounts
payable |
|
16,133 |
|
|
|
11,407 |
|
Accounts payable |
|
139,294 |
|
|
|
141,814 |
|
Advances from customers |
|
243,949 |
|
|
|
181,368 |
|
Deferred revenue |
|
8,537 |
|
|
|
3,687 |
|
Income taxes payable |
|
12,779 |
|
|
|
6,401 |
|
FIN-48 payable |
|
19,466 |
|
|
|
12,149 |
|
Other payables and accrued
expenses |
|
121,657 |
|
|
|
102,951 |
|
Current portion of operating
lease liability |
|
2,132 |
|
|
|
2,764 |
|
Total current liabilities |
|
641,233 |
|
|
|
500,659 |
|
Long-term borrowings |
|
105,525 |
|
|
|
53,952 |
|
Long-term operating lease
liability |
|
3,840 |
|
|
|
4,262 |
|
Other long-term liabilities |
|
9,217 |
|
|
|
5,873 |
|
Total liabilities |
|
759,815 |
|
|
|
564,746 |
|
Commitments and
contingencies |
|
|
|
Equity: |
|
|
|
Stockholders’ equity: |
|
|
|
Class A Common stock |
|
6 |
|
|
|
6 |
|
Class B Common stock |
|
1 |
|
|
|
1 |
|
Additional paid-in
capital |
|
677,476 |
|
|
|
629,845 |
|
Retained earnings |
|
260,000 |
|
|
|
156,827 |
|
Statutory surplus reserve |
|
30,514 |
|
|
|
30,060 |
|
Accumulated other
comprehensive loss |
|
(63,372 |
) |
|
|
(49,349 |
) |
Total ACM Research,
Inc. stockholders’ equity |
|
904,625 |
|
|
|
767,390 |
|
Non-controlling interests |
|
191,281 |
|
|
|
158,772 |
|
Total
equity |
|
1,095,906 |
|
|
|
926,162 |
|
Total liabilities and equity |
$ |
1,855,721 |
|
|
$ |
1,490,908 |
|
ACM RESEARCH, INC. |
Condensed Consolidated Statements of Operations and
Comprehensive Income |
|
|
Three Months Ended December 31, |
|
Year Ended December 31, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(Unaudited) |
|
( In thousands, except share and per share data) |
Revenue |
$ |
223,471 |
|
|
$ |
170,321 |
|
|
$ |
782,118 |
|
|
$ |
557,723 |
|
Cost of revenue |
|
112,656 |
|
|
|
91,245 |
|
|
|
390,564 |
|
|
|
281,508 |
|
Gross profit |
|
110,815 |
|
|
|
79,076 |
|
|
|
391,554 |
|
|
|
276,215 |
|
Operating expenses: |
|
|
|
|
|
|
|
Sales and marketing |
|
18,380 |
|
|
|
9,440 |
|
|
|
65,447 |
|
|
|
47,019 |
|
Research and development |
|
27,750 |
|
|
|
32,465 |
|
|
|
105,473 |
|
|
|
92,709 |
|
General and administrative |
|
20,696 |
|
|
|
13,797 |
|
|
|
69,636 |
|
|
|
40,648 |
|
Total operating expenses |
|
66,826 |
|
|
|
55,702 |
|
|
|
240,556 |
|
|
|
180,376 |
|
Income from operations |
|
43,989 |
|
|
|
23,374 |
|
|
|
150,998 |
|
|
|
95,839 |
|
Interest income |
|
2,813 |
|
|
|
2,071 |
|
|
|
9,935 |
|
|
|
8,354 |
|
Interest expense |
|
(1,228 |
) |
|
|
(697 |
) |
|
|
(4,151 |
) |
|
|
(2,681 |
) |
Realized
gain from sale of short-term investments |
|
1,344 |
|
|
|
478 |
|
|
|
1,788 |
|
|
|
9,047 |
|
Unrealized gain (loss) on short-term investments |
|
2,124 |
|
|
|
1,691 |
|
|
|
973 |
|
|
|
(2,737 |
) |
Other
income (expense), net |
|
7,061 |
|
|
|
(1,714 |
) |
|
|
6,334 |
|
|
|
(1,558 |
) |
Income
from equity method investments |
|
322 |
|
|
|
6,224 |
|
|
|
423 |
|
|
|
9,952 |
|
Income before income taxes |
|
56,425 |
|
|
|
31,427 |
|
|
|
166,300 |
|
|
|
116,216 |
|
Income tax expense |
|
(17,319 |
) |
|
|
(8,129 |
) |
|
|
(35,031 |
) |
|
|
(19,364 |
) |
Net income |
|
39,106 |
|
|
|
23,298 |
|
|
|
131,269 |
|
|
|
96,852 |
|
Less:
Net income attributable to non-controlling interests |
|
8,026 |
|
|
|
5,598 |
|
|
|
27,642 |
|
|
|
19,503 |
|
Net income attributable to ACM Research, Inc. |
$ |
31,080 |
|
|
$ |
17,700 |
|
|
$ |
103,627 |
|
|
$ |
77,349 |
|
Comprehensive income (loss): |
|
|
|
|
|
|
|
Net income |
|
39,106 |
|
|
|
23,298 |
|
|
|
131,269 |
|
|
|
96,852 |
|
Foreign currency translation adjustment, net of
tax |
|
(26,104 |
) |
|
|
11,214 |
|
|
|
(15,728 |
) |
|
|
(10,617 |
) |
Unrealized gain on available-for-sale investments, net of tax |
|
428 |
|
|
|
- |
|
|
|
428 |
|
|
|
- |
|
Comprehensive Income |
|
13,430 |
|
|
|
34,512 |
|
|
|
115,969 |
|
|
|
86,235 |
|
Less: Comprehensive income attributable to non-controlling
interests |
$ |
4,909 |
|
|
$ |
5,807 |
|
|
$ |
26,365 |
|
|
$ |
17,689 |
|
Comprehensive income (loss) attributable to ACM Research
Inc. |
$ |
8,521 |
|
|
$ |
28,705 |
|
|
$ |
89,604 |
|
|
$ |
68,546 |
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.49 |
|
|
$ |
0.29 |
|
|
$ |
1.67 |
|
|
$ |
1.29 |
|
Diluted |
$ |
0.46 |
|
|
$ |
0.26 |
|
|
$ |
1.53 |
|
|
$ |
1.16 |
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding used in computing per share
amounts: |
|
|
|
|
|
|
|
Basic |
|
62,794,259 |
|
|
|
60,792,349 |
|
|
|
62,212,569 |
|
|
|
60,164,670 |
|
Diluted |
|
66,518,704 |
|
|
|
65,911,901 |
|
|
|
66,237,424 |
|
|
|
64,870,543 |
|
ACM RESEARCH, INC. |
Total Revenue by Product Category and by
Region |
|
|
Three Months Ended December 31, |
|
Year Ended December 31, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
(Unaudited) |
|
($ in thousand) |
Single
wafer cleaning, Tahoe and semi-critical cleaning equipment |
$ |
155,211 |
|
$ |
122,292 |
|
$ |
578,887 |
|
$ |
403,851 |
ECP
(front-end and packaging), furnace and other technologies |
|
51,695 |
|
|
32,133 |
|
|
151,057 |
|
|
103,356 |
Advanced
packaging (excluding ECP), services & spares |
|
16,565 |
|
|
15,896 |
|
|
52,174 |
|
|
50,516 |
Total Revenue By Product Category |
$ |
223,471 |
|
$ |
170,321 |
|
$ |
782,118 |
|
$ |
557,723 |
|
Three Months Ended December 31, |
|
Year Ended December 31, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
Mainland
China |
$ |
223,110 |
|
$ |
165,441 |
|
$ |
775,752 |
|
$ |
540,969 |
Other
Regions |
|
361 |
|
|
4,880 |
|
|
6,366 |
|
|
16,754 |
Total Revenue By Region |
$ |
223,471 |
|
$ |
170,321 |
|
$ |
782,118 |
|
$ |
557,723 |
ACM RESEARCH,
INC.Reconciliation of GAAP to Non-GAAP Financial
Measures
As described under “Use of Non-GAAP Financial Measures” above,
ACM presents non-GAAP gross margin, operating expenses, operating
income, net income attributable to ACM Research, Inc., and basic
and diluted earnings per share as supplemental measures to GAAP
financial measures, each of which excludes stock-based compensation
(“SBC”) from the equivalent GAAP financial line items. In addition,
non-GAAP net income attributable to ACM Research, Inc., and basic
and diluted earnings per share exclude unrealized gain (loss) on
short-term investments. The following tables reconcile gross
margin, operating expenses, operating income, net income
attributable to ACM Research, Inc., and basic and diluted earnings
per share to the related non-GAAP financial measures:
|
Three Months Ended December 31, |
|
|
2024 |
|
|
|
2023 |
|
|
Actual (GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted (Non-GAAP) |
|
Actual (GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
(In thousands) |
Revenue |
$ |
223,471 |
|
|
$ |
- |
|
|
$ |
- |
|
$ |
223,471 |
|
|
$ |
170,321 |
|
|
$ |
- |
|
|
$ |
- |
|
$ |
170,321 |
|
Cost of revenue |
|
(112,656 |
) |
|
|
(365 |
) |
|
|
- |
|
|
(112,291 |
) |
|
|
(91,245 |
) |
|
|
(568 |
) |
|
|
- |
|
|
(90,677 |
) |
Gross profit |
|
110,815 |
|
|
|
(365 |
) |
|
|
- |
|
|
111,180 |
|
|
|
79,076 |
|
|
|
(568 |
) |
|
|
- |
|
|
79,644 |
|
Gross margin |
|
49.6 |
% |
|
|
0.2 |
% |
|
|
- |
|
|
49.8 |
% |
|
|
46.4 |
% |
|
|
0.3 |
% |
|
|
- |
|
|
46.8 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
(18,380 |
) |
|
|
(1,907 |
) |
|
|
- |
|
|
(16,473 |
) |
|
|
(9,440 |
) |
|
|
(2,279 |
) |
|
|
- |
|
|
(7,161 |
) |
Research and development |
|
(27,750 |
) |
|
|
(2,030 |
) |
|
|
- |
|
|
(25,720 |
) |
|
|
(32,465 |
) |
|
|
(3,628 |
) |
|
|
- |
|
|
(28,837 |
) |
General and administrative |
|
(20,696 |
) |
|
|
(4,482 |
) |
|
|
- |
|
|
(16,214 |
) |
|
|
(13,797 |
) |
|
|
(6,197 |
) |
|
|
- |
|
|
(7,600 |
) |
Total operating expenses |
|
(66,826 |
) |
|
|
(8,419 |
) |
|
|
- |
|
|
(58,407 |
) |
|
|
(55,702 |
) |
|
|
(12,104 |
) |
|
|
- |
|
|
(43,598 |
) |
Income (loss) from operations |
$ |
43,989 |
|
|
$ |
(8,784 |
) |
|
$ |
- |
|
$ |
52,773 |
|
|
$ |
23,374 |
|
|
$ |
(12,672 |
) |
|
$ |
- |
|
$ |
36,046 |
|
Unrealized gain on short-term investments |
|
2,124 |
|
|
|
- |
|
|
|
2,124 |
|
|
- |
|
|
|
1,691 |
|
|
|
- |
|
|
|
1,691 |
|
|
- |
|
Net income (loss) attributable to ACM Research,
Inc. |
$ |
31,080 |
|
|
$ |
(8,784 |
) |
|
$ |
2,124 |
|
$ |
37,740 |
|
|
$ |
17,700 |
|
|
$ |
(12,672 |
) |
|
$ |
1,691 |
|
$ |
28,681 |
|
Basic EPS |
$ |
0.49 |
|
|
|
|
|
|
$ |
0.60 |
|
|
$ |
0.29 |
|
|
|
|
|
|
$ |
0.47 |
|
Diluted EPS |
$ |
0.46 |
|
|
|
|
|
|
$ |
0.56 |
|
|
$ |
0.26 |
|
|
|
|
|
|
$ |
0.43 |
|
|
Year Ended December 31, |
|
|
2024 |
|
|
|
2023 |
|
|
Actual (GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted (Non-GAAP) |
|
Actual (GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
(In thousands) |
Revenue |
$ |
782,118 |
|
|
$ |
- |
|
|
$ |
- |
|
$ |
782,118 |
|
|
$ |
557,723 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
557,723 |
|
Cost of revenue |
|
(390,564 |
) |
|
|
(2,385 |
) |
|
|
- |
|
|
(388,179 |
) |
|
|
(281,508 |
) |
|
|
(1,406 |
) |
|
|
- |
|
|
|
(280,102 |
) |
Gross profit |
|
391,554 |
|
|
|
(2,385 |
) |
|
|
- |
|
|
393,939 |
|
|
|
276,215 |
|
|
|
(1,406 |
) |
|
|
- |
|
|
|
277,621 |
|
Gross margin |
|
50.1 |
% |
|
|
0.3 |
% |
|
|
- |
|
|
50.4 |
% |
|
|
49.5 |
% |
|
|
0.3 |
% |
|
|
- |
|
|
|
49.8 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
(65,447 |
) |
|
|
(10,552 |
) |
|
|
- |
|
|
(54,895 |
) |
|
|
(47,019 |
) |
|
|
(5,684 |
) |
|
|
- |
|
|
|
(41,335 |
) |
Research and development |
|
(105,473 |
) |
|
|
(14,112 |
) |
|
|
- |
|
|
(91,361 |
) |
|
|
(92,709 |
) |
|
|
(8,459 |
) |
|
|
- |
|
|
|
(84,250 |
) |
General and administrative |
|
(69,636 |
) |
|
|
(22,527 |
) |
|
|
- |
|
|
(47,109 |
) |
|
|
(40,648 |
) |
|
|
(11,789 |
) |
|
|
- |
|
|
|
(28,859 |
) |
Total operating expenses |
|
(240,556 |
) |
|
|
(47,191 |
) |
|
|
- |
|
|
(193,365 |
) |
|
|
(180,376 |
) |
|
|
(25,932 |
) |
|
|
- |
|
|
|
(154,444 |
) |
Income (loss) from operations |
$ |
150,998 |
|
|
$ |
(49,576 |
) |
|
$ |
- |
|
$ |
200,574 |
|
|
$ |
95,839 |
|
|
$ |
(27,338 |
) |
|
$ |
- |
|
|
$ |
123,177 |
|
Unrealized gain (loss) on short-term investments |
|
973 |
|
|
|
- |
|
|
|
973 |
|
|
- |
|
|
|
(2,737 |
) |
|
|
- |
|
|
|
(2,737 |
) |
|
|
- |
|
Net income (loss) attributable to ACM Research,
Inc. |
$ |
103,627 |
|
|
$ |
(49,576 |
) |
|
$ |
973 |
|
$ |
152,230 |
|
|
$ |
77,349 |
|
|
$ |
(27,338 |
) |
|
$ |
(2,737 |
) |
|
$ |
107,424 |
|
Basic EPS |
$ |
1.67 |
|
|
|
|
|
|
$ |
2.45 |
|
|
$ |
1.29 |
|
|
|
|
|
|
$ |
1.79 |
|
Diluted EPS |
$ |
1.53 |
|
|
|
|
|
|
$ |
2.26 |
|
|
$ |
1.16 |
|
|
|
|
|
|
$ |
1.63 |
|
ACM Research (NASDAQ:ACMR)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
ACM Research (NASDAQ:ACMR)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025